−3JPY
−305.31 MJPY
2.95 BJPY
84.38 M
About REPROCELL INCORPORATED
Sector
Industry
Headquarters
Yokohama
Website
Employees (FY)
92
Founded
2003
ISIN
JP3974770004
FIGI
BBG004MBZJZ4
ReproCELL, Inc. engages in stem cell research. It operates through the following segments: Research Support and Medical. The Research Support segment includes reagents and drug discovery support in the Induced Pluripotent Stem (iPS) cell business. The Medical segment deals with regenerative medicine in the iPS cell business and clinical testing services. The company was founded by Norio Nakatsuji and Hiromitsu Nakauchi on February 26, 2003 and is headquartered in Yokohama, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4978 is 137 JPY — it has decreased by 3.52% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange REPROCELL INCORPORATED stocks are traded under the ticker 4978.
REPROCELL INCORPORATED is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
4978 stock is 6.77% volatile and has beta coefficient of 1.31. Check out the list of the most volatile stocks — is REPROCELL INCORPORATED there?
4978 earnings for the last quarter are −0.14 JPY per share, whereas the estimation was −2.14 JPY resulting in a 93.46% surprise. The estimated earnings for the next quarter are −0.94 JPY per share. See more details about REPROCELL INCORPORATED earnings.
REPROCELL INCORPORATED revenue for the last quarter amounts to 591.00 M JPY despite the estimated figure of 563.63 M JPY. In the next quarter revenue is expected to reach 720.00 M JPY.
Yes, you can track REPROCELL INCORPORATED financials in yearly and quarterly reports right on TradingView.
4978 stock has fallen by 6.80% compared to the previous week, the month change is a 13.84% fall, over the last year REPROCELL INCORPORATED has showed a 44.76% decrease.
4978 net income for the last quarter is −12.47 M JPY, while the quarter before that showed −11.26 M JPY of net income which accounts for −10.70% change. Track more REPROCELL INCORPORATED financial stats to get the full picture.
Today REPROCELL INCORPORATED has the market capitalization of 12.63 B, it has decreased by 2.61% over the last week.
No, 4978 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 4978 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REPROCELL INCORPORATED stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 92.00 employees. See our rating of the largest employees — is REPROCELL INCORPORATED on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REPROCELL INCORPORATED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REPROCELL INCORPORATED stock shows the strong sell signal. See more of REPROCELL INCORPORATED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REPROCELL INCORPORATED EBITDA is −391.83 M JPY, and current EBITDA margin is −10.40%. See more stats in REPROCELL INCORPORATED financial statements.